Beth Ledvora, MD
Psychiatry · Palos Heights, ILNPI 1104993161
Payments from drug & device makers
Across 713 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Lundbeck LLC$1K
- Vanda Pharmaceuticals Inc.$1K
- Neurocrine Biosciences, Inc.$989
- Johnson & Johnson$971
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$867
- plus $5K from 25 others
What the payments were for
- Food & beverage$12,92499%
- Education$1131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 159 | $2,859 |
| Lundbeck LLC | 68 | $1,147 |
| Vanda Pharmaceuticals Inc. | 40 | $1,009 |
| Neurocrine Biosciences, Inc. | 44 | $989 |
| Johnson & Johnson | 49 | $971 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 41 | $867 |
| Otsuka America Pharmaceutical, Inc. | 49 | $772 |
| Eisai Inc. | 32 | $412 |
| Axsome Therapeutics, Inc. | 19 | $402 |
| Alkermes, Inc. | 22 | $383 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $357 |
| Corium, LLC | 20 | $356 |
| Bausch Health US, LLC | 21 | $344 |
| Teva Pharmaceuticals USA, Inc. | 20 | $288 |
| Sunovion Pharmaceuticals Inc. | 17 | $244 |
| Supernus Pharmaceuticals, Inc. | 11 | $230 |
| Jazz Pharmaceuticals Inc. | 8 | $214 |
| Idorsia Pharmaceuticals US Inc | 12 | $204 |
| Tris Pharma Inc | 10 | $187 |
| Ironshore Pharmaceuticals Inc. | 8 | $165 |
| Neos Therapeutics, LP | 7 | $117 |
| Adlon Therapeutics L.p. | 7 | $103 |
| Almatica Pharma LLC | 5 | $94 |
| Shire North American Group Inc | 6 | $89 |
| E.r. Squibb & Sons, L.L.C. | 3 | $74 |
| OWP Pharmaceuticals, Inc. | 2 | $38 |
| Noven Therapeutics, LLC | 2 | $34 |
| Acadia Pharmaceuticals Inc | 2 | $32 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $22 |
| Neuronetics, Inc. | 1 | $20 |
| Rhodes Pharmaceuticals L.p. | 1 | $12 |
How this compares
$13,037 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 67 | $82,980 |
| RexultiBrexpiprazole | 27 | $69,784 |
| VraylarCariprazine Hcl | 14 | $42,952 |
| Lurasidone Hcl | 14 | $12,777 |
| Bupropion XlBupropion Hcl | 241 | $5,938 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 68 | $5,595 |
| XanaxAlprazolam | 12 | $5,480 |
| Escitalopram Oxalate | 321 | $4,392 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $4,322 |
| Alprazolam | 367 | $3,634 |
| Varenicline Tartrate | 13 | $3,402 |
| Temazepam | 188 | $3,368 |
| Lorazepam | 305 | $3,358 |
| Trazodone Hcl | 167 | $3,335 |
| Adderall XrDextroamphetamine/Amphetamine | 14 | $3,322 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $357 | $87,30278 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $772 | $69,78427 claims |
| AbbVieVraylar | $2,859 | $42,95214 claims |
| Almatica Pharma LLCSertraline Hcl | $94 | $1,794196 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Palos Heights
- Jeffrey RossNorthbrook$10.8M
- Yuhwen ChowChicago$8.5M
- Mark LermanNorthbrook$4.5M
- Danesh AlamWinfield$2.7M
- John ZajeckaSkokie$2.5M
- Riaz BaberNaperville$2.4M
- Michael GreenbaumLibertyville$2.2M
- Sandeep GaonkarNaperville$1.8M
- Jon GrantChicago$1.4M
- David KempOak Lawn$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.